2-169701576-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001008489.4(PHOSPHO2):c.605A>T(p.Tyr202Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001008489.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHOSPHO2 | NM_001008489.4 | c.605A>T | p.Tyr202Phe | missense_variant | 4/4 | ENST00000359744.8 | NP_001008489.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHOSPHO2 | ENST00000359744.8 | c.605A>T | p.Tyr202Phe | missense_variant | 4/4 | 1 | NM_001008489.4 | ENSP00000352782.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249566Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135018
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459864Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726288
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.605A>T (p.Y202F) alteration is located in exon 4 (coding exon 1) of the PHOSPHO2 gene. This alteration results from a A to T substitution at nucleotide position 605, causing the tyrosine (Y) at amino acid position 202 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at